The effect of multimodality treatment and HPV infection in oropharyngeal squamous cell carcinoma.

The effect of multimodality treatment and HPV infection in oropharyngeal squamous cell carcinoma. - Multimodality treatment and HPV in oropharyngeal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013476

Enrollment

213

Registered

2014-06-01

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oropharyngeal squamous cell carcinoma

Interventions

chemotherapy, chemoradiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Squamous cell carcinoma of oropharynx Stage III/IV PS 1 OR 2 No prior treatment

Exclusion criteria

Exclusion criteria: Patients with surgical treatment Distant metastasis Double cancer

Design outcomes

Primary

Measure	Time frame
The efficacy of multi modality treatment and HPV detection in cancer cells	—

Countries

Japan

Contacts

Public ContactMasato Fujii

National Hospital Organization Tokyo Medical Cencter Otolaryngology

fujiimasato@kankakuki.go.jp03-3411-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026